| Mylan Pharma GmbH - Influvac, Injektionssuspension | | 00485 | | 23 | | Influvac | | Injektionssuspension | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 23.08.2010 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) et neuraminidasum inactivatum (Virus-Stamm A/California/7/2009 (H1N1)-derived strain used reass. virus NYMC X-181) 15 µg, haemagglutininum influenzae A (H3N2) et neuraminidasum inactivatum (Virus-Stamm A/Perth/16/2009 (H3N2)-like str.used reass.v. NYMC X-187 deriv. A/Victoria/210/2009) 15 µg, haemagglutininum influenzae et neuraminidasum inactivatum (Virus-Stamm B/Brisbane/60/2008) 15 µg.
kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: ovalbuminum max. 1 µg, saccharum et formaldehydum et cetrimidum et polysorbatum 80 et gentamicinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Injection suspension | | | |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
